Danny Gilad Allouche - 01 Mar 2026 Form 4 Insider Report for Avery Dennison Corp (AVY)

Role
SVP & CSDO
Signature
/s/ Vikas Arora, attorney-in-fact for Danny Gilad Allouche
Issuer symbol
AVY
Transactions as of
01 Mar 2026
Net transactions value
+$281,847
Form type
4
Filing time
03 Mar 2026, 16:26:26 UTC
Previous filing
02 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Allouche Danny Gilad SVP & CSDO 8080 NORTON PKWY, MENTOR /s/ Vikas Arora, attorney-in-fact for Danny Gilad Allouche 03 Mar 2026 0002045672

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVY Common Stock Options Exercise $90,767 +466 +2.1% $194.78 22,172 01 Mar 2026 Trust
transaction AVY Common Stock Tax liability $39,346 -202 -0.91% $194.78 21,970 01 Mar 2026 Trust
transaction AVY Common Stock Options Exercise $68,563 +352 +1.6% $194.78 22,322 01 Mar 2026 Trust
transaction AVY Common Stock Tax liability $27,659 -142 -0.64% $194.78 22,180 01 Mar 2026 Trust
transaction AVY Common Stock Options Exercise $45,968 +236 +1.1% $194.78 22,416 01 Mar 2026 Trust
transaction AVY Common Stock Tax liability $17,725 -91 -0.41% $194.78 22,325 01 Mar 2026 Trust
transaction AVY Common Stock Options Exercise $114,920 +590 +2.6% $194.78 22,915 01 Mar 2026 Trust
transaction AVY Common Stock Tax liability $46,552 -239 -1% $194.78 22,676 01 Mar 2026 Trust
transaction AVY Common Stock Options Exercise $154,071 +791 +3.5% $194.78 23,467 01 Mar 2026 Trust
transaction AVY Common Stock Tax liability $61,161 -314 -1.3% $194.78 23,153 01 Mar 2026 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVY 2026 RSU Award Award $0 +2,183 $0.000000 2,183 01 Mar 2026 Common Stock 2,183 $0.000000 Direct F1
transaction AVY 2026 PU Award Award $0 +3,157 $0.000000 3,157 01 Mar 2026 Common Stock 3,157 $0.000000 Direct F2
transaction AVY 2022 MSU Award Options Exercise $0 -466 -100% $0.000000 0 01 Mar 2026 Common Stock 466 $0.000000 Direct F3
transaction AVY 2023 MSU Award Options Exercise $0 -352 -50% $0.000000 348 01 Mar 2026 Common Stock 352 $0.000000 Direct F4
transaction AVY 2024 MSU Award Options Exercise $0 -236 -32% $0.000000 495 01 Mar 2026 Common Stock 236 $0.000000 Direct F5
transaction AVY 2025 MSU Award Options Exercise $0 -590 -24% $0.000000 1,847 01 Mar 2026 Common Stock 590 $0.000000 Direct F6
transaction AVY 2023 PU Award Options Exercise $0 -791 -100% $0.000000 0 01 Mar 2026 Common Stock 791 $0.000000 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock.
F2 Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock.
F3 Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period.
F4 Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period.
F5 Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period.
F6 Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period.
F7 Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target.